Literature DB >> 26076070

FlexAID: Revisiting Docking on Non-Native-Complex Structures.

Francis Gaudreault1, Rafael J Najmanovich1.   

Abstract

Small-molecule protein docking is an essential tool in drug design and to understand molecular recognition. In the present work we introduce FlexAID, a small-molecule docking algorithm that accounts for target side-chain flexibility and utilizes a soft scoring function, i.e. one that is not highly dependent on specific geometric criteria, based on surface complementarity. The pairwise energy parameters were derived from a large dataset of true positive poses and negative decoys from the PDBbind database through an iterative process using Monte Carlo simulations. The prediction of binding poses is tested using the widely used Astex dataset as well as the HAP2 dataset, while performance in virtual screening is evaluated using a subset of the DUD dataset. We compare FlexAID to AutoDock Vina, FlexX, and rDock in an extensive number of scenarios to understand the strengths and limitations of the different programs as well as to reported results for Glide, GOLD, and DOCK6 where applicable. The most relevant among these scenarios is that of docking on flexible non-native-complex structures where as is the case in reality, the target conformation in the bound form is not known a priori. We demonstrate that FlexAID, unlike other programs, is robust against increasing structural variability. FlexAID obtains equivalent sampling success as GOLD and performs better than AutoDock Vina or FlexX in all scenarios against non-native-complex structures. FlexAID is better than rDock when there is at least one critical side-chain movement required upon ligand binding. In virtual screening, FlexAID results are lower on average than those of AutoDock Vina and rDock. The higher accuracy in flexible targets where critical movements are required, intuitive PyMOL-integrated graphical user interface and free source code as well as precompiled executables for Windows, Linux, and Mac OS make FlexAID a welcome addition to the arsenal of existing small-molecule protein docking methods.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26076070     DOI: 10.1021/acs.jcim.5b00078

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  9 in total

1.  Force Field Optimization Guided by Small Molecule Crystal Lattice Data Enables Consistent Sub-Angstrom Protein-Ligand Docking.

Authors:  Hahnbeom Park; Guangfeng Zhou; Minkyung Baek; David Baker; Frank DiMaio
Journal:  J Chem Theory Comput       Date:  2021-02-12       Impact factor: 6.006

2.  GalaxyDock BP2 score: a hybrid scoring function for accurate protein-ligand docking.

Authors:  Minkyung Baek; Woong-Hee Shin; Hwan Won Chung; Chaok Seok
Journal:  J Comput Aided Mol Des       Date:  2017-06-16       Impact factor: 3.686

Review 3.  Crowd sourcing difficult problems in protein science.

Authors:  Nathan S Alexander; Krzysztof Palczewski
Journal:  Protein Sci       Date:  2017-08-29       Impact factor: 6.725

4.  NRGsuite: a PyMOL plugin to perform docking simulations in real time using FlexAID.

Authors:  Francis Gaudreault; Louis-Philippe Morency; Rafael J Najmanovich
Journal:  Bioinformatics       Date:  2015-08-06       Impact factor: 6.937

5.  Large-scale detection of drug off-targets: hypotheses for drug repurposing and understanding side-effects.

Authors:  Matthieu Chartier; Louis-Philippe Morency; María Inés Zylber; Rafael J Najmanovich
Journal:  BMC Pharmacol Toxicol       Date:  2017-04-28       Impact factor: 2.483

6.  Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis.

Authors:  Magdi E A Zaki; Sami A Al-Hussain; Vijay H Masand; Siddhartha Akasapu; Sumit O Bajaj; Nahed N E El-Sayed; Arabinda Ghosh; Israa Lewaa
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-13

7.  QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA.

Authors:  Rahul D Jawarkar; Ravindra L Bakal; Nobendu Mukherjee; Arabinda Ghosh; Magdi E A Zaki; Sami A Al-Hussain; Aamal A Al-Mutairi; Abdul Samad; Ajaykumar Gandhi; Vijay H Masand
Journal:  Molecules       Date:  2022-07-25       Impact factor: 4.927

8.  Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells.

Authors:  Somnath Pandey; Rahinatou Djibo; Anaïs Darracq; Gennaro Calendo; Hanghang Zhang; Ryan A Henry; Andrew J Andrews; Stephen B Baylin; Jozef Madzo; Rafael Najmanovich; Jean-Pierre J Issa; Noël J-M Raynal
Journal:  Cancers (Basel)       Date:  2022-07-08       Impact factor: 6.575

9.  High-performance virtual screening by targeting a high-resolution RNA dynamic ensemble.

Authors:  Laura R Ganser; Janghyun Lee; Atul Rangadurai; Dawn K Merriman; Megan L Kelly; Aman D Kansal; Bharathwaj Sathyamoorthy; Hashim M Al-Hashimi
Journal:  Nat Struct Mol Biol       Date:  2018-05-04       Impact factor: 15.369

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.